Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

crawled date : 2021 - 04 - 12    crawled time : 06:00    save search

What-Our-Partners-are-Saying
Published: 2021-04-12 (Crawled : 06:00) - ooma.com
OOMA 4 | $6.99 -0.43% 12K twitter stocktwits trandingview |
Technology Services
| | O: -0.24% H: 0.0% C: -0.73%


Why-Partner-with-Ooma
Published: 2021-04-12 (Crawled : 06:00) - ooma.com
OOMA 4 | $6.99 -0.43% 12K twitter stocktwits trandingview |
Technology Services
| | O: -0.24% H: 0.0% C: -0.73%


Phase 3 Prevention Trial Showed 81% Reduced Risk of Symptomatic SARS-CoV-2 Infections with Subcutaneous Administration of REGEN-COV™ (casirivimab with imdevimab)
Published: 2021-04-12 (Crawled : 06:00) - prnewswire.com
SNY | News | $46.34 2.09% 620K twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 0.12% C: -0.69%
REGN | $894.35 0.04% 140K twitter stocktwits trandingview |
Health Technology
| | O: 1.39% H: 0.0% C: -1.86%

risk phase 3 trial casirivimab injection sars-cov-2 infections
Cosmo announces FDA approval of GI Genius™ intelligent endoscopy module, its revolutionary Artificial Intelligence device for lesion detection during colonoscopy
Published: 2021-04-12 (Crawled : 06:00) - prnewswire.com
MDT | $79.49 0.38% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.2% H: 0.42% C: 0.03%

artificial intelligence fda endoscopy fda approval device approval
Phase 3 Treatment Trial in Recently Infected Asymptomatic Patients Showed REGEN-COV™ (casirivimab with imdevimab) Significantly Reduced Progression to Symptomatic COVID-19
Published: 2021-04-12 (Crawled : 06:00) - prnewswire.com
SNY | News | $46.34 2.09% 620K twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 0.12% C: -0.69%
REGN | $894.35 0.04% 140K twitter stocktwits trandingview |
Health Technology
| | O: 1.39% H: 0.0% C: -1.86%

covid treatment phase 3 trial casirivimab injection infections
Walmart China and Dada Group's JDDJ Expand Collaboration on Omni-Channel Customer Digitalization
Published: 2021-04-12 (Crawled : 06:00) - prnewswire.com
DADA | $1.885 2.45% 230K twitter stocktwits trandingview |
Technology Services
| | O: -0.39% H: 3.54% C: -2.82%

china collaboration
Gainers vs Losers
79% 21%

Top 10 Gainers
AGBA | News | $1.22 205.0% 86M twitter stocktwits trandingview |
Finance

EGOX | $0.0606 68.33% 250M twitter stocktwits trandingview |

NVFY | $3.45 63.51% 20M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.98 36.55% 27M twitter stocktwits trandingview |
Commercial Services

CHRO | $1.66 35.51% 70K twitter stocktwits trandingview |
n/a

INDO | $5.43 33.09% 10M twitter stocktwits trandingview |
Energy Minerals

PAPL | $2.07 26.22% 550K twitter stocktwits trandingview |

RWOD | $10.08 26.05% 5.6M twitter stocktwits trandingview |
n/a

AULT | $0.304 25.57% 47M twitter stocktwits trandingview |
Manufacturing

HUSA 4 | $2.07 23.95% 2.1M twitter stocktwits trandingview |
Energy Minerals


Your saved searches
Save your searches and get alerts when important news are released.